Tag: Cancer: Breast
Guidance Statements Issued for Breast Cancer Screening
Clinicians should discuss mammography with patients aged 40 to 49, discontinue screening for those ≥75
Ibrance Approval Expanded to Include Men With Breast Cancer
Kinase inhibitor approved in combination with endocrine therapy for male patients with breast cancer
AACR: Surgery Tied to Improved Survival in HER2+ Breast Cancer
In addition to targeted medication, adjuvant therapy, surgery improves survival in stage IV disease
State Breast Density Notification Laws May Up Ultrasound Use
But laws should require notification of possible benefits of supplemental screening
Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
Fewer benign biopsies necessary with DBT compared with full-field digital mammography
Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone
Parity, Risk for Breast Cancer Studied for BRCA1/2 Carriers
Higher risk seen in uniparous BRCA1 carriers, parous BRCA2 carriers; breastfeeding cuts risk in BRCA1
Acupressure Reduces Lasting Symptoms in Breast Cancer Survivors
Tied to improvements in pain, anxiety, depression among breast cancer survivors with fatigue
FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Genetic Testing Recommended for All Patients With Breast Cancer
All with personal history of breast cancer should be offered testing; updated testing recommended
